Robot-Assisted Gait Training vs NMES in Parkinson's Disease
Trial
N/A
Recruiting
May 14, 2026
A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History Study
Trial
N/A
Not yet recruiting
May 14, 2026
An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
Trial
N/A
Active, not recruiting
May 14, 2026
Light Therapy for Parkinson’s Disease
News
A Closer Look Archives | American Parkinson Disease Association
May 14, 2026
Subthalamic nucleus deep brain stimulation connectivity related to apathy outcomes in Parkinson's disease*
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
May 14, 2026
Sensory Function Improves With Subthalamic Nucleus Stimulation in Parkinson's: A Network Analysis.
Research
Neuromodulation : journal of the International Neuromodulation Society
May 14, 2026
Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's Disease
Trial
N/A
Not yet recruiting
May 13, 2026
Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation
Trial
N/A
Completed
May 13, 2026
China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration
Trial
N/A
Enrolling by invitation
May 13, 2026
Phase 1/2a Study of ANPD001 in Parkinson Disease
Trial
Phase 1
Enrolling by invitation
May 13, 2026
Rhythmic Auditory Stimulation on Upper-limb Movements in PD Patients
Trial
N/A
Completed
May 13, 2026
Dopaminergic restauratIon by intraVEntriculaire Administration
Trial
Phase 1
Completed
May 13, 2026
Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)
Trial
Phase 4
Completed
May 13, 2026
Personalized Real-Time DBS and PD Mechanisms
Trial
Phase 4
Recruiting
May 13, 2026
Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease
Trial
Phase 2
Completed
May 13, 2026
Cognitive Phenotypes in Parkinson's Disease
Trial
N/A
Completed
May 13, 2026
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
Trial
Phase 4
Completed
May 13, 2026
Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes
Trial
N/A
Completed
May 13, 2026
Autonomic Dysfunction and Parkinson’s
News
Brian Grant Foundation
May 13, 2026